<DOC>
	<DOCNO>NCT00897936</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict well patient respond treatment . PURPOSE : This laboratory study look tissue sample patient acute myeloid leukemia .</brief_summary>
	<brief_title>DNA Analysis Tumor Tissue From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine gene expression , genome integrity , cytosine methylation , chromatin structure patient normal cytogenetics leukemia ( NCL ) acute myeloid leukemia . - Determine whether NCL deconstruct specific disease entity analysis integrate genomic epigenomic datasets use supervise unsupervised method patient . - Identify gene pathway define NCL subtypes molecular target validation preclinical clinical trial patient . - Determine whether integrated analysis provide marker prognostic therapeutic response accurately predict clinical outcome use select patient risk-stratified therapeutic trial . OUTLINE : This pilot , multicenter study . Samples analyze assess array comparative genomic hybridization use polymerase chain reaction ( PCR ) fluorescent situ hybridization ; chromatin immunoprecipitations ( chip ) use PCR ; Hpa II tiny fragment enrichment ligation-mediated PCR ( HELP ) use DNA methylation analysis ; gene expression profile . PROJECTED ACCRUAL : A total 32 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia Enrolled clinical trial ECOGE1900 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
</DOC>